Table 3. Pain, discomfort and anxiety experienced during relevant screening tests, as reported by participating women in the T2 questionnaire (n=288: 147 women CBE, 141 women CBE+mammography+MRI).
| CBE (n=287)a | Mammography (n=134)a | MRI (n=109)a | |
|---|---|---|---|
| Pain (%) | |||
| Not | 92.6 | 14.3 | 88.0 |
| A little | 6.7 | 55.6 | 11.1 |
| Quite | 0.7 | 21.1 | 0.9 |
| Very | 0 | 9.0 | 0 |
| Discomfort (%) | |||
| Not | 91.5 | 30.8 | 54.6 |
| A little | 7.4 | 47.4 | 36.1 |
| Quite | 0.7 | 15.8 | 4.6 |
| Very | 0.4 | 6.0 | 4.6 |
| Anxiety (%) | |||
| Not | 77.9 | 72.4 | 63.0 |
| A little | 20.4 | 22.4 | 26.9 |
| Quite | 1.4 | 4.5 | 7.4 |
| Very | 0.4 | 0.7 | 2.8 |
CBE=clinical breast examination; MRI=magnetic resonance imaging.
a
One of 288 women reported no CBE during last screening; seven of 141 women reported no mammography during last screening; 32 of 141 women reported no MRI during last screening.